SCHEMBL6321979

SCHEMBL6321979

CCCCN(CCCC)c1nc2c(nc1C#N)c(=O)n(C)c(=O)n2C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.40
POLB P06746 2/20 0.40
THRB P10828 1/20 0.40
BLM P54132 1/20 0.40
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 3/20 0.38
LMNA P02545 3/20 0.38
HTT P42858 3/20 0.38
HPGD P15428 2/20 0.38
JAK2 O60674 1/20 0.38
PAX8 Q06710 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
RECQL P46063 1/20 0.37
TSHR P16473 3/20 0.34
MAPK1 P28482 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NR2F2 P24468 1/20 0.34
ADORA2A P29274 2/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6316332 0.72 ALDH1A1 (0.62) MAPTPOLBTHRBBLMALDH1A1
SCHEMBL6313912 0.69 ALDH1A1 (0.58) MAPTPOLBTHRBBLMALDH1A1
SCHEMBL30629172 0.69 MAPT (0.43) MAPTTHRBALDH1A1KDM4ELMNA
SCHEMBL26312966 0.66 ALDH1A1 (0.66) MAPTPOLBTHRBBLMALDH1A1
SCHEMBL6396069 0.66 MAPT (0.40) MAPTPOLBTHRBBLMALDH1A1
SCHEMBL5443256 0.65 ALDH1A1 (0.35) MAPTPOLBTHRBBLMALDH1A1
SCHEMBL6316818 0.65 ALDH1A1 (0.40) MAPTPOLBTHRBBLMALDH1A1
SCHEMBL10524326 0.65 ALDH1A1 (0.63) MAPTPOLBTHRBBLMALDH1A1
SCHEMBL5448291 0.64 ALDH1A1 (0.73) MAPTPOLBTHRBBLMALDH1A1
SCHEMBL6314771 0.64 KDM4E (0.58) MAPTBLMALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US claimed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US claimed
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US disclosed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives TPMT, FKBP5, RRP15 MAPT 388/4885POLB 3139/4885THRB 3197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.